DICLOFENAC POTASSIUM TABLETS

DICLOFENAC POTASSIUM TABLETS was reported 8670 times

DICLOFENAC POTASSIUM TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 135 0.5895
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 381 0.5704
2 HEPATIC ENZYME 81 0.5436
3 C-REACTIVE PROTEIN 489 0.5275
4 LUPUS VULGARIS 658 0.5222
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1016 0.5072
6 SWOLLEN JOINT COUNT 114 0.4560
7 SWOLLEN JOINT COUNT INCREASED 1381 0.4326
8 FACET JOINT SYNDROME 1345 0.4127
9 RHEUMATIC FEVER 1832 0.4106
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 729 0.3515
11 RETINITIS 604 0.3493
12 HYPOCHOLESTEROLAEMIA 120 0.3399
13 DISLOCATION OF VERTEBRA 741 0.3246
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
15 X-RAY ABNORMAL 516 0.2883
16 DUODENAL ULCER PERFORATION 2102 0.2824
17 RHEUMATOID FACTOR POSITIVE 1616 0.2795
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28 0.2667
19 SERONEGATIVE ARTHRITIS 287 0.2504
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1794 0.2501
21 PERIPHERAL VENOUS DISEASE 983 0.2405
22 HELICOBACTER INFECTION 2149 0.2089
23 MUSCLE INJURY 1609 0.1940
24 PORPHYRIA ACUTE 277 0.1930
25 C-REACTIVE PROTEIN ABNORMAL 1196 0.1863
26 PEMPHIGUS 2316 0.1851
27 ACQUIRED PORPHYRIA 13 0.1831
28 BONE EROSION 641 0.1811
29 FOLLICULITIS 1832 0.1745
30 HAND DEFORMITY 2259 0.1721
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 95 0.1693
32 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1073 0.1651
33 LIP DRY 1446 0.1590
34 BREAST CANCER STAGE III 1013 0.1563
35 TENDER JOINT COUNT 13 0.1548
36 PERICARDITIS 2248 0.1337
37 SYNOVITIS 2291 0.1269
38 JOINT RANGE OF MOTION DECREASED 1608 0.1198
39 MUSCULOSKELETAL DEFORMITY 28 0.1197
40 HYPERCHOLESTEROLAEMIA 1155 0.1195
41 GRIP STRENGTH DECREASED 965 0.1095
42 DEAFNESS TRANSITORY 93 0.1089
43 WOUND INFECTION 1164 0.1062
44 AUTOIMMUNE DISORDER 1027 0.1053
45 BURSITIS 1252 0.1031
46 GLOSSODYNIA 2293 0.1023
47 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
48 DEATH NEONATAL 130 0.0934
49 LIVE BIRTH 757 0.0904
50 DRUG TOLERANCE DECREASED 246 0.0875
51 IRRITABLE BOWEL SYNDROME 1845 0.0860
52 WOUND 2383 0.0852
53 BLEPHAROSPASM 536 0.0850
54 FIBROMYALGIA 1959 0.0805
55 ONYCHOMADESIS 331 0.0788
56 LIVER INJURY 1789 0.0728
57 SCIATICA 1135 0.0711
58 SYSTEMIC LUPUS ERYTHEMATOSUS 2490 0.0701
59 EXOSTOSIS 623 0.0682
60 LUPUS-LIKE SYNDROME 604 0.0665
61 MATERNAL EXPOSURE TIMING UNSPECIFIED 244 0.0649
62 TYPE 2 DIABETES MELLITUS 2176 0.0646
63 OBESITY 982 0.0616
64 IMPAIRED HEALING 1886 0.0574
65 ONYCHOMYCOSIS 252 0.0574
66 LOWER LIMB FRACTURE 1087 0.0565
67 OVERLAP SYNDROME 38 0.0543
68 RED BLOOD CELL SEDIMENTATION RATE INCREASED 597 0.0539
69 PSORIATIC ARTHROPATHY 2165 0.0533
70 PRESCRIBED OVERDOSE 1028 0.0531
71 JOINT DISLOCATION 551 0.0521
72 JOINT DESTRUCTION 81 0.0521
73 WRIST DEFORMITY 32 0.0520
74 SPONDYLITIS 189 0.0519
75 WALKING AID USER 340 0.0515
76 NAIL DISORDER 436 0.0498
77 CONTRAINDICATED PRODUCT ADMINISTERED 1489 0.0491
78 PULMONARY FIBROSIS 900 0.0469
79 INFUSION SITE REACTION 140 0.0468
80 FOOT DEFORMITY 500 0.0451
81 HIP ARTHROPLASTY 658 0.0429
82 BREAST CANCER STAGE II 354 0.0425
83 NAIL OPERATION 17 0.0411
84 ANTIPHOSPHOLIPID ANTIBODIES 8 0.0410
85 PRESCRIBED UNDERDOSE 809 0.0405
86 BLOOD CHOLESTEROL INCREASED 1827 0.0392
87 ARTHROPATHY 2079 0.0374
88 NIGHT SWEATS 1174 0.0364
89 LOWER RESPIRATORY TRACT INFECTION 1616 0.0355
90 GAIT INABILITY 1186 0.0355
91 ULCER HAEMORRHAGE 240 0.0354
92 OSTEOARTHRITIS 1497 0.0353
93 VASCULAR ACCESS COMPLICATION 28 0.0346
94 SYNOVIAL FLUID ANALYSIS 3 0.0345
95 INFUSION RELATED REACTION 2266 0.0342
96 HEPATIC CIRRHOSIS 616 0.0328
97 BLISTER 1821 0.0324
98 HEPATIC ENZYME INCREASED 2204 0.0323
99 MEAN PLATELET VOLUME DECREASED 27 0.0322
100 THERAPEUTIC PRODUCT EFFECT DECREASED 1395 0.0311
101 FINGER DEFORMITY 148 0.0305
102 CONGENITAL ANOMALY 234 0.0302
103 SPINAL FUSION SURGERY 121 0.0298
104 ROAD TRAFFIC ACCIDENT 1227 0.0293
105 STOMATITIS 1766 0.0291
106 DISCOMFORT 1774 0.0290
107 WHEEZING 1718 0.0289
108 KNEE ARTHROPLASTY 605 0.0287
109 C-REACTIVE PROTEIN INCREASED 1042 0.0286
110 TEMPERATURE REGULATION DISORDER 59 0.0265
111 PUSTULAR PSORIASIS 90 0.0262
112 FUNCTIONAL GASTROINTESTINAL DISORDER 89 0.0257
113 INJURY 1805 0.0257
114 MOBILITY DECREASED 1815 0.0252
115 LUNG DISORDER 1229 0.0251
116 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 427 0.0249
117 PRODUCT LABEL CONFUSION 145 0.0249
118 INFLAMMATION 1279 0.0248
119 COELIAC DISEASE 241 0.0245
120 LIVER DISORDER 1076 0.0242
121 SWELLING 2244 0.0240
122 BACK INJURY 259 0.0238
123 TASTE DISORDER 483 0.0238
124 MUSCULOSKELETAL PAIN 1230 0.0235
125 RHEUMATOID ARTHRITIS 2660 0.0234
126 JOINT STIFFNESS 607 0.0231
127 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 12 0.0229
128 EAR INFECTION 609 0.0229
129 OEDEMA 1240 0.0228
130 LIVER FUNCTION TEST INCREASED 481 0.0224
131 EYE INJURY 66 0.0217
132 ILL-DEFINED DISORDER 1313 0.0216
133 DELIRIUM 749 0.0216
134 INTESTINAL DIAPHRAGM DISEASE 6 0.0215
135 EMBOLIA CUTIS MEDICAMENTOSA 17 0.0214
136 DRUG TOLERANCE 108 0.0213
137 EPILEPSY 640 0.0209
138 DRUG INTOLERANCE 1948 0.0201
139 BLOODY DISCHARGE 23 0.0201
140 JOINT SWELLING 2416 0.0200
141 MATERNAL EXPOSURE DURING PREGNANCY 1777 0.0199
142 SYNOVIAL DISORDER 9 0.0198
143 TREATMENT FAILURE 1640 0.0198
144 MUSCULOSKELETAL STIFFNESS 1730 0.0197
145 NORMAL NEWBORN 105 0.0193
146 PREGNANCY 385 0.0192
147 SHOULDER ARTHROPLASTY 51 0.0189
148 DRY MOUTH 1489 0.0183
149 SLEEP DISORDER 1273 0.0180
150 GENERAL PHYSICAL HEALTH DETERIORATION 2071 0.0179
151 RASH VESICULAR 86 0.0178
152 MEAN CELL VOLUME DECREASED 27 0.0175
153 DRUG-INDUCED LIVER INJURY 549 0.0175
154 INTENTIONAL PRODUCT USE ISSUE 1499 0.0171
155 SPONDYLOARTHROPATHY 10 0.0167
156 THERAPY NON-RESPONDER 745 0.0166
157 EAR PAIN 308 0.0158
158 INTERSTITIAL GRANULOMATOUS DERMATITIS 3 0.0155
159 MEAN CELL HAEMOGLOBIN DECREASED 28 0.0153
160 DISABILITY 298 0.0151
161 GASTROINTESTINAL DISORDER 1317 0.0147
162 DUCTUS ARTERIOSUS STENOSIS FOETAL 6 0.0141
163 EXPOSURE DURING PREGNANCY 871 0.0140
164 OSTEOPOROSIS 573 0.0139
165 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 235 0.0138
166 SINUSITIS 1418 0.0138
167 ADVERSE REACTION 183 0.0138
168 HYPOAESTHESIA 2051 0.0137
169 CONTUSION 1302 0.0135
170 ABDOMINAL DISCOMFORT 2206 0.0131
171 SUSPECTED OFF LABEL USE 59 0.0130
172 BRONCHIAL HYPERREACTIVITY 14 0.0116
173 MUSCLE SPASTICITY 143 0.0116
174 SPINAL STENOSIS 48 0.0116
175 INTERNATIONAL NORMALISED RATIO FLUCTUATION 24 0.0116
176 HYPERSENSITIVITY 2146 0.0115
177 KOUNIS SYNDROME 26 0.0114
178 INFECTION 1653 0.0114
179 PHARYNGITIS 140 0.0113
180 GASTROINTESTINAL PROCEDURAL COMPLICATION 3 0.0112
181 ALOPECIA 2157 0.0110
182 AMNESIA 714 0.0110
183 GENERAL SYMPTOM 82 0.0109
184 FREQUENT BOWEL MOVEMENTS 293 0.0108
185 INSPIRATORY CAPACITY DECREASED 3 0.0108
186 TENOSYNOVITIS STENOSANS 6 0.0108
187 DAIRY INTOLERANCE 3 0.0107
188 RESPIRATORY DISORDER 319 0.0107
189 MIGRAINE 1016 0.0106
190 URTICARIA 1770 0.0106
191 BLOOD CHOLESTEROL 5 0.0105
192 WEIGHT FLUCTUATION 110 0.0105
193 PERIPHERAL SWELLING 1599 0.0104
194 FOOT OPERATION 51 0.0103
195 ROTATOR CUFF REPAIR 18 0.0103
196 CONFUSIONAL STATE 1631 0.0101
197 DYSPEPSIA 982 0.0100
198 HYPERTENSION 2101 0.0099
199 ASTHMA 1099 0.0097
200 MYOSITIS 87 0.0097
201 FOETAL DEATH 50 0.0096
202 GASTROINTESTINAL PAIN 106 0.0096
203 PRODUCT USED FOR UNKNOWN INDICATION 12 0.0095
204 POLYARTHRITIS 50 0.0095
205 UPPER RESPIRATORY TRACT INFECTION 428 0.0093
206 NASOPHARYNGITIS 1679 0.0091
207 COLONIC STENOSIS 3 0.0087
208 ABNORMAL LOSS OF WEIGHT 59 0.0086
209 MEDICATION ERROR 481 0.0086
210 ADVERSE EVENT 778 0.0084
211 ADVERSE DRUG REACTION 743 0.0083
212 MEMORY IMPAIRMENT 1135 0.0083
213 EXCESSIVE EYE BLINKING 12 0.0081
214 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 390 0.0081
215 WEIGHT INCREASED 1811 0.0081
216 BACK DISORDER 129 0.0079
217 MONOCYTE COUNT INCREASED 28 0.0077
218 PULMONARY FUNCTION TEST ABNORMAL 12 0.0077
219 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 548 0.0077
220 LYME DISEASE 25 0.0075
221 MUSCULAR WEAKNESS 850 0.0075
222 GASTROOESOPHAGEAL REFLUX DISEASE 599 0.0074
223 ANKYLOSING SPONDYLITIS 98 0.0074
224 PRODUCT USE ISSUE 1384 0.0074
225 DECREASED APPETITE 1691 0.0073
226 OEDEMA PERIPHERAL 874 0.0072
227 IMMUNODEFICIENCY 106 0.0071
228 MILIARIA 12 0.0070
229 ABDOMINAL PAIN UPPER 1419 0.0069
230 FOOD ALLERGY 53 0.0069
231 TENDERNESS 71 0.0068
232 COLITIS ULCERATIVE 304 0.0068
233 BONE MARROW OEDEMA 7 0.0068
234 ARTHRITIS 519 0.0066
235 PARAESTHESIA 1031 0.0065
236 RECTAL HAEMORRHAGE 280 0.0065
237 DIAPHRAGMATIC HERNIA 4 0.0065
238 HEPATITIS 163 0.0064
239 SACROILIITIS 12 0.0064
240 MUSCLE SPASMS 1166 0.0063
241 CHEST PAIN 1134 0.0061
242 WHITE BLOOD CELL COUNT INCREASED 234 0.0061
243 LABORATORY TEST ABNORMAL 178 0.0060
244 CONDITION AGGRAVATED 1806 0.0059
245 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
246 NON-ALCOHOLIC STEATOHEPATITIS 6 0.0058
247 RASH 2495 0.0057
248 PRODUCT USE IN UNAPPROVED INDICATION 1407 0.0057
249 PHYSICAL DISABILITY 25 0.0056
250 ALLERGY TO CHEMICALS 7 0.0056
251 JOINT ARTHROPLASTY 10 0.0056
252 GLOMERULONEPHRITIS MINIMAL LESION 4 0.0055
253 SOFT TISSUE INJURY 4 0.0053
254 ARTHRALGIA 2145 0.0052
255 IRON DEFICIENCY 23 0.0051
256 THERAPEUTIC RESPONSE DECREASED 310 0.0051
257 DACTYLITIS 5 0.0051
258 UNDERDOSE 372 0.0051
259 PANCREATITIS 269 0.0051
260 JOINT EFFUSION 35 0.0051
261 GAIT DISTURBANCE 947 0.0049
262 FEELING HOT 303 0.0049
263 HYPERTRANSAMINASAEMIA 34 0.0049
264 VISUAL IMPAIRMENT 605 0.0049
265 MUSCULOSKELETAL DISORDER 92 0.0048
266 NECK PAIN 267 0.0048
267 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 11 0.0048
268 DEPRESSION 1064 0.0047
269 ADRENAL INSUFFICIENCY 56 0.0046
270 FLUID RETENTION 230 0.0045
271 FEEDING DISORDER 91 0.0045
272 ENTHESOPATHY 7 0.0045
273 VULVOVAGINAL CANDIDIASIS 6 0.0044
274 INSOMNIA 1163 0.0044
275 PYREXIA 1499 0.0043
276 PLATELET COUNT INCREASED 54 0.0041
277 VOMITING 1938 0.0041
278 BREAST CANCER STAGE I 38 0.0041
279 MASTOIDITIS 4 0.0041
280 PAIN 2464 0.0040
281 ISCHAEMIC CARDIOMYOPATHY 12 0.0039
282 PAIN IN EXTREMITY 1151 0.0039
283 BRONCHITIS 286 0.0039
284 DEAFNESS 101 0.0039
285 DEFORMITY 36 0.0038
286 INJECTION SITE REACTION 262 0.0038
287 PRURITUS 1452 0.0038
288 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
289 TACHYCARDIA 333 0.0037
290 SCLERITIS 6 0.0037
291 HYPOPHAGIA 95 0.0037
292 POST-TRAUMATIC NECK SYNDROME 3 0.0037
293 ASTHENIA 1393 0.0037
294 MALAISE 1609 0.0037
295 SEROUS RETINAL DETACHMENT 3 0.0036
296 PSORIASIS 465 0.0036
297 ANXIETY 1004 0.0035
298 PRE-EXISTING CONDITION IMPROVED 22 0.0035
299 PNEUMONIA 1129 0.0035
300 PRODUCT QUALITY ISSUE 463 0.0034
301 RIGHT VENTRICULAR HYPERTROPHY 3 0.0033
302 WEIGHT DECREASED 919 0.0033
303 RUBBER SENSITIVITY 5 0.0033
304 FATIGUE 2540 0.0033
305 ABDOMINAL PAIN 756 0.0032
306 DIZZINESS 1615 0.0032
307 ASPIRATION 35 0.0032
308 HEADACHE 2002 0.0032
309 PREGNANCY AFTER POST COITAL CONTRACEPTION 7 0.0031
310 SEDATION 81 0.0031
311 ANTIBIOTIC THERAPY 3 0.0031
312 RECTAL POLYP 3 0.0030
313 BODY TEMPERATURE INCREASED 62 0.0030
314 HAEMANGIOMA 7 0.0030
315 BONE DEMINERALISATION 3 0.0028
316 CATAPLEXY 4 0.0028
317 OFF LABEL USE 2469 0.0028
318 FOETAL EXPOSURE DURING PREGNANCY 226 0.0028
319 INCORRECT PRODUCT ADMINISTRATION DURATION 60 0.0028
320 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
321 DYSPNOEA 1521 0.0027
322 CREPITATIONS 8 0.0027
323 DIARRHOEA 1661 0.0026
324 RHEUMATOID NODULE 7 0.0025
325 PLEURITIC PAIN 7 0.0025
326 BREATH SOUNDS ABNORMAL 12 0.0024
327 SYNOVIAL CYST 11 0.0024
328 SPINAL DEFORMITY 4 0.0024
329 FOOD AVERSION 4 0.0024
330 NIGHTMARE 81 0.0023
331 LYMPHOCYTOSIS 5 0.0023
332 ABDOMINAL SEPSIS 2 0.0023
333 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
334 TERMINAL INSOMNIA 4 0.0023
335 MOVEMENT DISORDER 72 0.0022
336 PANCREATIC DISORDER 11 0.0022
337 ULCERATIVE KERATITIS 6 0.0022
338 CUSHINGOID 7 0.0022
339 TENOSYNOVITIS 6 0.0022
340 INFECTED SKIN ULCER 4 0.0021
341 NAUSEA 1665 0.0021
342 SECRETION DISCHARGE 25 0.0020
343 EATING DISORDER 42 0.0020
344 MUSCLE CONTRACTURE 4 0.0020
345 INTENTIONAL PRODUCT MISUSE 171 0.0020
346 PREMATURE SEPARATION OF PLACENTA 3 0.0019
347 NEURITIS 3 0.0019
348 ATTENTION DEFICIT HYPERACTIVITY DISORDER 8 0.0019
349 GASTRIC ULCER 36 0.0019
350 PROTEIN TOTAL INCREASED 5 0.0019
351 DRUG INEFFECTIVE 2470 0.0019
352 PAIN IN JAW 53 0.0019
353 DEREALISATION 4 0.0019
354 NEPHROLITHIASIS 85 0.0019
355 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
356 RESPIRATORY TRACT INFECTION 47 0.0018
357 ARTHROPOD STING 3 0.0018
358 DERMATITIS EXFOLIATIVE 9 0.0018
359 RHINITIS ALLERGIC 8 0.0018
360 SEIZURE LIKE PHENOMENA 3 0.0018
361 DERMATITIS ALLERGIC 22 0.0017
362 FIXED ERUPTION 3 0.0017
363 THROMBOCYTOPENIA 192 0.0017
364 INFUSION SITE DISCHARGE 3 0.0017
365 IMPAIRED WORK ABILITY 36 0.0017
366 OVERWEIGHT 9 0.0017
367 RASH PRURITIC 89 0.0016
368 ESSENTIAL HYPERTENSION 3 0.0016
369 ABDOMINAL DISTENSION 171 0.0016
370 DECREASED IMMUNE RESPONSIVENESS 16 0.0016
371 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
372 DRUG ERUPTION 27 0.0015
373 HOSPITALISATION 234 0.0015
374 RADICULOPATHY 4 0.0015
375 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
376 PLANTAR FASCIITIS 5 0.0015
377 VAGINAL INFECTION 7 0.0015
378 RASH ERYTHEMATOUS 71 0.0015
379 TREATMENT NONCOMPLIANCE 80 0.0015
380 IMPAIRED SELF-CARE 3 0.0014
381 HANGOVER 5 0.0014
382 STAPHYLOCOCCAL SEPSIS 7 0.0014
383 INCREASED TENDENCY TO BRUISE 13 0.0014
384 REACTION TO DRUG EXCIPIENTS 3 0.0014
385 SPINAL DISORDER 13 0.0014
386 POOR VENOUS ACCESS 14 0.0014
387 GASTROINTESTINAL ULCER 3 0.0014
388 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
389 SNORING 5 0.0013
390 IRITIS 4 0.0013
391 PAINFUL RESPIRATION 3 0.0012
392 BLOOD PRESSURE SYSTOLIC ABNORMAL 3 0.0012
393 PEPTIC ULCER 4 0.0012
394 HYPERPARATHYROIDISM SECONDARY 3 0.0012
395 VENTRICULAR HYPERTROPHY 3 0.0012
396 TUBERCULIN TEST POSITIVE 3 0.0012
397 LEUKOPENIA 59 0.0012
398 CONCUSSION 9 0.0012
399 TACHYPHRENIA 4 0.0012
400 HYPOKALAEMIA 53 0.0011
401 BACK PAIN 266 0.0011
402 RENAL CYST 9 0.0011
403 NASAL DISORDER 3 0.0011
404 ANIMAL BITE 3 0.0011
405 HYPERHIDROSIS 145 0.0011
406 CONJUNCTIVAL HYPERAEMIA 4 0.0011
407 WEIGHT BEARING DIFFICULTY 3 0.0011
408 POST PROCEDURAL INFECTION 9 0.0011
409 ENDOTRACHEAL INTUBATION 3 0.0011
410 SKIN INFECTION 12 0.0011
411 SLEEP APNOEA SYNDROME 20 0.0010
412 VITAMIN B12 DECREASED 3 0.0010
413 ACCIDENTAL OVERDOSE 38 0.0010
414 STAPHYLOCOCCAL INFECTION 34 0.0010
415 NECK INJURY 3 0.0010
416 ONYCHOCLASIS 7 0.0010
417 LARGE INTESTINE PERFORATION 7 0.0010
418 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
419 TRIGEMINAL NEURALGIA 4 0.0010
420 MUSCULOSKELETAL DISCOMFORT 17 0.0010
421 BRONCHOSPASM 14 0.0010
422 ANAPHYLACTIC REACTION 54 0.0010
423 FIBROSIS 3 0.0010
424 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
425 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
426 ERYTHEMA MULTIFORME 9 0.0010
427 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
428 HALLUCINATIONS, MIXED 4 0.0010
429 OVERDOSE 205 0.0009
430 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
431 CARDIOMYOPATHY 14 0.0009
432 PRODUCT COMPLAINT 24 0.0009
433 SPINAL PAIN 11 0.0009
434 ATELECTASIS 9 0.0009
435 SKIN EROSION 3 0.0009
436 TENSION HEADACHE 4 0.0009
437 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
438 NODULE 12 0.0009
439 EOSINOPHILIA 16 0.0009
440 FALL 303 0.0009
441 OTITIS MEDIA 3 0.0009
442 PHOTOPHOBIA 17 0.0009
443 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
444 GASTROENTERITIS VIRAL 16 0.0009
445 TRICUSPID VALVE INCOMPETENCE 7 0.0009
446 NEUROLOGICAL SYMPTOM 5 0.0009
447 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
448 EXERCISE TOLERANCE DECREASED 5 0.0009
449 HYPOPNOEA 3 0.0009
450 CONJUNCTIVITIS 16 0.0009
451 GASTRITIS EROSIVE 4 0.0009
452 EYE DISORDER 28 0.0009
453 SPINAL COLUMN STENOSIS 4 0.0008
454 SKIN ABRASION 4 0.0008
455 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
456 RETCHING 18 0.0008
457 MUSCULOSKELETAL CHEST PAIN 13 0.0008
458 DERMATITIS BULLOUS 6 0.0008
459 FOOD INTOLERANCE 3 0.0008
460 AMYLASE INCREASED 3 0.0008
461 ARTHROPOD BITE 6 0.0008
462 HYPERVOLAEMIA 4 0.0008
463 LIGAMENT SPRAIN 8 0.0008
464 SCOLIOSIS 5 0.0008
465 INFUSION SITE EXTRAVASATION 5 0.0008
466 CHRONIC SINUSITIS 3 0.0008
467 DISEASE RECURRENCE 38 0.0008
468 AUTOIMMUNE THYROIDITIS 3 0.0008
469 PARANASAL SINUS DISCOMFORT 3 0.0008
470 TOOTH ABSCESS 8 0.0008
471 SKIN REACTION 11 0.0008
472 EYE PAIN 44 0.0008
473 ANKLE FRACTURE 12 0.0008
474 ORAL INFECTION 3 0.0008
475 ORAL CANDIDIASIS 10 0.0008
476 MOUTH ULCERATION 16 0.0008
477 ARTERIOSPASM CORONARY 3 0.0007
478 FLANK PAIN 7 0.0007
479 METASTASES TO LYMPH NODES 5 0.0007
480 SINUS CONGESTION 10 0.0007
481 FOOT FRACTURE 14 0.0007
482 TRIGGER FINGER 3 0.0007
483 CYST 9 0.0007
484 AORTIC DISSECTION 3 0.0007
485 HEART RATE ABNORMAL 4 0.0007
486 PHARYNGEAL SWELLING 7 0.0007
487 ANGIOPATHY 4 0.0007
488 BONE DISORDER 13 0.0007
489 BODY TEMPERATURE DECREASED 7 0.0007
490 EJECTION FRACTION DECREASED 11 0.0007
491 TONGUE DISCOMFORT 3 0.0007
492 HEPATIC PAIN 3 0.0007
493 PRODUCT DISPENSING ISSUE 3 0.0007
494 HORDEOLUM 3 0.0007
495 DYSPHEMIA 3 0.0007
496 SPINAL OSTEOARTHRITIS 6 0.0007
497 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
498 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
499 QUALITY OF LIFE DECREASED 9 0.0007
500 SYMPTOM RECURRENCE 4 0.0007
501 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
502 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
503 DEEP VEIN THROMBOSIS 42 0.0006
504 APHONIA 9 0.0006
505 ROSACEA 3 0.0006
506 SKIN LACERATION 7 0.0006
507 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
508 SUSPECTED SUICIDE 3 0.0006
509 LOSS OF CONSCIOUSNESS 82 0.0006
510 TIBIA FRACTURE 3 0.0006
511 SEASONAL ALLERGY 9 0.0006
512 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
513 NERVE INJURY 7 0.0006
514 ANAPHYLACTIC SHOCK 16 0.0006
515 DYSSTASIA 18 0.0006
516 HEPATITIS ACUTE 4 0.0006
517 TENDON DISORDER 4 0.0006
518 RENAL TUBULAR NECROSIS 6 0.0006
519 BEDRIDDEN 8 0.0006
520 RESTLESS LEGS SYNDROME 11 0.0006
521 ILLNESS 62 0.0006
522 HEPATIC ENZYME ABNORMAL 3 0.0006
523 BRAIN INJURY 6 0.0006
524 HAEMATEMESIS 15 0.0006
525 PATHOLOGICAL FRACTURE 3 0.0006
526 UVEITIS 8 0.0006
527 LIMB INJURY 16 0.0006
528 VITAMIN D DECREASED 5 0.0006
529 BURNING SENSATION 41 0.0006
530 SKIN LESION 16 0.0006
531 TEMPERATURE INTOLERANCE 6 0.0006
532 BLOOD URINE PRESENT 11 0.0006
533 BASAL CELL CARCINOMA 9 0.0006
534 ANHEDONIA 15 0.0006
535 GASTRITIS 15 0.0006
536 HAND FRACTURE 4 0.0006
537 THERMAL BURN 4 0.0006
538 RESPIRATORY RATE INCREASED 5 0.0006
539 FEAR OF INJECTION 4 0.0006
540 BRUXISM 3 0.0006
541 BIPOLAR DISORDER 6 0.0006
542 HYDROCEPHALUS 3 0.0006
543 END STAGE RENAL DISEASE 10 0.0005
544 PRODUCT PRESCRIBING ERROR 13 0.0005
545 STEVENS-JOHNSON SYNDROME 12 0.0005
546 PRODUCT DISTRIBUTION ISSUE 5 0.0005
547 FEELING DRUNK 4 0.0005
548 NEPHROPATHY 5 0.0005
549 GENERALISED ERYTHEMA 3 0.0005
550 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
551 MICTURITION URGENCY 6 0.0005
552 INTERNAL HAEMORRHAGE 6 0.0005
553 FEELING JITTERY 10 0.0005
554 DRY EYE 26 0.0005
555 METABOLIC DISORDER 3 0.0005
556 PALLOR 14 0.0005
557 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
558 MULTIPLE ALLERGIES 4 0.0005
559 CYANOSIS 8 0.0005
560 ENERGY INCREASED 3 0.0005
561 ODYNOPHAGIA 3 0.0005
562 CYSTITIS 16 0.0005
563 BLOOD PRESSURE FLUCTUATION 12 0.0005
564 VAGINAL DISCHARGE 5 0.0005
565 INGUINAL HERNIA 3 0.0005
566 NO ADVERSE EVENT 89 0.0005
567 THROAT IRRITATION 22 0.0005
568 NEUTROPHIL COUNT INCREASED 5 0.0005
569 INITIAL INSOMNIA 5 0.0005
570 ESCHERICHIA INFECTION 4 0.0005
571 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
572 PIGMENTATION DISORDER 3 0.0005
573 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
574 HEART RATE DECREASED 17 0.0005
575 PRODUCTIVE COUGH 23 0.0005
576 OXYGEN SATURATION DECREASED 27 0.0005
577 INFUSION SITE SWELLING 3 0.0005
578 CELLULITIS 24 0.0005
579 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
580 DIABETES MELLITUS 36 0.0005
581 BODY HEIGHT DECREASED 5 0.0005
582 GASTRIC DISORDER 16 0.0005
583 ABNORMAL SENSATION IN EYE 2 0.0005
584 INCOHERENT 3 0.0005
585 CONSTIPATION 101 0.0005
586 PHARYNGITIS STREPTOCOCCAL 5 0.0005
587 ECONOMIC PROBLEM 7 0.0005
588 HYSTERECTOMY 4 0.0005
589 PYELONEPHRITIS 4 0.0005
590 HYPONATRAEMIA 26 0.0005
591 OSTEOPENIA 7 0.0005
592 ORAL HERPES 9 0.0005
593 SURGERY 27 0.0005
594 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
595 SOMNAMBULISM 3 0.0005
596 LYMPHOMA 7 0.0005
597 NEURALGIA 11 0.0005
598 SWOLLEN TONGUE 14 0.0004
599 HAEMARTHROSIS 4 0.0004
600 PRODUCT LABEL ISSUE 3 0.0004
601 IMPAIRED GASTRIC EMPTYING 6 0.0004
602 ULCER 7 0.0004
603 RIB FRACTURE 9 0.0004
604 NERVE COMPRESSION 4 0.0004
605 AUTOIMMUNE HEPATITIS 3 0.0004
606 HEPATIC STEATOSIS 8 0.0004
607 MASS 6 0.0004
608 DRUG INTERACTION 68 0.0004
609 CARPAL TUNNEL SYNDROME 6 0.0004
610 DUODENAL ULCER 3 0.0004
611 PULMONARY TOXICITY 3 0.0004
612 ERYTHEMA 87 0.0004
613 HYPOCALCAEMIA 8 0.0004
614 FRACTURE 8 0.0004
615 INFLUENZA 47 0.0004
616 OROPHARYNGEAL PAIN 39 0.0004
617 VIRAL INFECTION 14 0.0004
618 LIMB DISCOMFORT 13 0.0004
619 FUNGAL INFECTION 14 0.0004
620 RED BLOOD CELL COUNT DECREASED 12 0.0004
621 ACCIDENT 5 0.0004
622 WRIST FRACTURE 5 0.0004
623 PARAESTHESIA ORAL 6 0.0004
624 SUICIDAL IDEATION 38 0.0004
625 LOCALISED INFECTION 10 0.0004
626 FAECES SOFT 3 0.0004
627 GASTROENTERITIS 6 0.0004
628 MAJOR DEPRESSION 3 0.0004
629 SPINAL OPERATION 5 0.0004
630 HEPATOTOXICITY 9 0.0004
631 GENERALISED OEDEMA 5 0.0004
632 SNEEZING 9 0.0004
633 HERPES ZOSTER 23 0.0004
634 OVARIAN CYST 4 0.0004
635 SWELLING FACE 26 0.0004
636 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
637 SLUGGISHNESS 4 0.0004
638 EAR DISCOMFORT 4 0.0004
639 ROTATOR CUFF SYNDROME 5 0.0004
640 APHTHOUS ULCER 3 0.0004
641 OSTEOMYELITIS 7 0.0004
642 HIATUS HERNIA 5 0.0004
643 APNOEA 3 0.0004
644 PANIC ATTACK 14 0.0004
645 PETECHIAE 4 0.0004
646 PNEUMOTHORAX 6 0.0004
647 DEPRESSED MOOD 20 0.0004
648 EYE HAEMORRHAGE 5 0.0004
649 JOINT INJURY 8 0.0004
650 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
651 RHINITIS 3 0.0004
652 MENTAL IMPAIRMENT 9 0.0004
653 COLITIS 14 0.0004
654 FAECES DISCOLOURED 8 0.0004
655 DECUBITUS ULCER 3 0.0004
656 PNEUMONITIS 10 0.0004
657 MELAENA 8 0.0004
658 EMBOLISM 3 0.0004
659 HYPOMAGNESAEMIA 5 0.0004
660 SINUS DISORDER 7 0.0004
661 CARDIAC DISORDER 33 0.0004
662 HEPATOCELLULAR INJURY 5 0.0004
663 IMPAIRED DRIVING ABILITY 4 0.0004
664 BONE DENSITY DECREASED 11 0.0004
665 INTENTIONAL DOSE OMISSION 10 0.0004
666 DRUG RESISTANCE 9 0.0004
667 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
668 HYPOTENSION 70 0.0003
669 GASTRIC HAEMORRHAGE 4 0.0003
670 BLOOD MAGNESIUM DECREASED 3 0.0003
671 HEAD INJURY 11 0.0003
672 PSYCHOLOGICAL TRAUMA 3 0.0003
673 EXPOSURE VIA SKIN CONTACT 9 0.0003
674 SEIZURE 40 0.0003
675 MENTAL DISORDER 15 0.0003
676 BLOOD CALCIUM INCREASED 3 0.0003
677 RHINORRHOEA 22 0.0003
678 SKIN HAEMORRHAGE 5 0.0003
679 BLOOD IRON DECREASED 4 0.0003
680 FACIAL PAIN 3 0.0003
681 BLOOD PRESSURE INCREASED 51 0.0003
682 TOOTHACHE 6 0.0003
683 NOCTURIA 4 0.0003
684 CHRONIC KIDNEY DISEASE 25 0.0003
685 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
686 IRON DEFICIENCY ANAEMIA 3 0.0003
687 THYROID DISORDER 5 0.0003
688 ABASIA 8 0.0003
689 NASAL CONGESTION 19 0.0003
690 TOOTH EXTRACTION 4 0.0003
691 APPENDICITIS 3 0.0003
692 DIARRHOEA HAEMORRHAGIC 3 0.0003
693 SPUTUM DISCOLOURED 3 0.0003
694 DEATH 270 0.0003
695 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
696 FEELING ABNORMAL 75 0.0003
697 METABOLIC ACIDOSIS 10 0.0003
698 MYDRIASIS 4 0.0003
699 PANCREATITIS ACUTE 7 0.0003
700 CARDIO-RESPIRATORY ARREST 13 0.0003
701 URINARY TRACT INFECTION 53 0.0003
702 HERNIA 6 0.0003
703 SKIN ULCER 8 0.0003
704 VITAMIN D DEFICIENCY 3 0.0003
705 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
706 INFLAMMATORY BOWEL DISEASE 3 0.0003
707 KIDNEY INFECTION 6 0.0003
708 SPEECH DISORDER 16 0.0003
709 KNEE OPERATION 3 0.0003
710 MULTIPLE FRACTURES 5 0.0003
711 PULMONARY CONGESTION 4 0.0003
712 RENAL INJURY 9 0.0003
713 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
714 RESTLESSNESS 11 0.0003
715 SKIN DISORDER 10 0.0003
716 BLOOD POTASSIUM DECREASED 9 0.0003
717 THROMBOSIS 24 0.0003
718 VERTIGO 18 0.0003
719 OCULAR HYPERAEMIA 14 0.0003
720 COUGH 82 0.0003
721 PERIPHERAL COLDNESS 4 0.0003
722 TOOTH LOSS 6 0.0003
723 RHABDOMYOLYSIS 12 0.0003
724 HUNGER 4 0.0003
725 COORDINATION ABNORMAL 4 0.0003
726 FULL BLOOD COUNT ABNORMAL 3 0.0003
727 BLINDNESS UNILATERAL 4 0.0003
728 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
729 SKIN DISCOLOURATION 13 0.0003
730 HEAD DISCOMFORT 5 0.0003
731 COVID-19 49 0.0003
732 IMPAIRED QUALITY OF LIFE 4 0.0003
733 DISTURBANCE IN ATTENTION 15 0.0003
734 UNEVALUABLE EVENT 21 0.0003
735 VISION BLURRED 38 0.0003
736 COMPLETED SUICIDE 23 0.0003
737 OESOPHAGITIS 3 0.0003
738 DISEASE PROGRESSION 32 0.0003
739 VENTRICULAR FIBRILLATION 3 0.0003
740 TOOTH DISORDER 6 0.0003
741 PULMONARY MASS 4 0.0003
742 RASH PAPULAR 6 0.0003
743 BALANCE DISORDER 23 0.0003
744 MYALGIA 45 0.0003
745 POLLAKIURIA 11 0.0003
746 DERMATITIS CONTACT 3 0.0003
747 SCAB 3 0.0003
748 HAEMOGLOBIN DECREASED 27 0.0003
749 RENAL IMPAIRMENT 22 0.0003
750 RENAL FAILURE ACUTE 11 0.0003
751 TREMOR 43 0.0003
752 TENDONITIS 4 0.0003
753 RASH MACULAR 9 0.0003
754 THERAPY PARTIAL RESPONDER 4 0.0003
755 NERVOUS SYSTEM DISORDER 8 0.0003
756 SKIN FISSURES 5 0.0003
757 BRAIN FOG 4 0.0003
758 LYMPHADENOPATHY 9 0.0003
759 RESPIRATORY DISTRESS 7 0.0003
760 DYSPHAGIA 24 0.0003
761 DIVERTICULITIS 7 0.0003
762 PULMONARY EMBOLISM 24 0.0003
763 RESPIRATORY TRACT CONGESTION 4 0.0003
764 BLOOD PRESSURE ABNORMAL 5 0.0003
765 MOOD SWINGS 8 0.0003
766 HAEMOPTYSIS 7 0.0003
767 INTERSTITIAL LUNG DISEASE 12 0.0002
768 PRODUCT ADMINISTRATION ERROR 5 0.0002
769 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
770 ABNORMAL FAECES 2 0.0002
771 CHOLELITHIASIS 8 0.0002
772 CARDIOMEGALY 3 0.0002
773 SMALL INTESTINAL OBSTRUCTION 3 0.0002
774 INJECTION SITE WARMTH 5 0.0002
775 AGEUSIA 6 0.0002
776 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
777 URINARY RETENTION 8 0.0002
778 NEOPLASM MALIGNANT 16 0.0002
779 DYSPNOEA EXERTIONAL 9 0.0002
780 BLOOD UREA INCREASED 4 0.0002
781 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
782 FACE OEDEMA 4 0.0002
783 SOMNOLENCE 47 0.0002
784 POOR QUALITY SLEEP 5 0.0002
785 MULTI-ORGAN FAILURE 4 0.0002
786 SUICIDE ATTEMPT 14 0.0002
787 IMMUNE SYSTEM DISORDER 3 0.0002
788 TOOTH INFECTION 3 0.0002
789 ANGIOEDEMA 10 0.0002
790 LETHARGY 13 0.0002
791 RENAL FAILURE 30 0.0002
792 GALLBLADDER DISORDER 4 0.0002
793 ACUTE KIDNEY INJURY 34 0.0002
794 NEUROPATHY PERIPHERAL 21 0.0002
795 AKATHISIA 3 0.0002
796 GINGIVAL BLEEDING 3 0.0002
797 ACUTE HEPATIC FAILURE 3 0.0002
798 TINNITUS 10 0.0002
799 SEPSIS 24 0.0002
800 EYE SWELLING 8 0.0002
801 THINKING ABNORMAL 4 0.0002
802 THERAPY CESSATION 11 0.0002
803 BLOOD TEST ABNORMAL 3 0.0002
804 DEVICE OCCLUSION 3 0.0002
805 BLOOD SODIUM DECREASED 4 0.0002
806 SINUS TACHYCARDIA 3 0.0002
807 PARALYSIS 3 0.0002
808 POST PROCEDURAL COMPLICATION 4 0.0002
809 SEROTONIN SYNDROME 4 0.0002
810 LIVER FUNCTION TEST ABNORMAL 6 0.0002
811 APATHY 3 0.0002
812 ASCITES 6 0.0002
813 INJECTION SITE URTICARIA 5 0.0002
814 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
815 INTENTIONAL OVERDOSE 13 0.0002
816 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
817 NEOPLASM PROGRESSION 7 0.0002
818 PRODUCT DOSE OMISSION ISSUE 59 0.0002
819 EPISTAXIS 15 0.0002
820 CARDIAC FAILURE 16 0.0002
821 HYPOAESTHESIA ORAL 3 0.0002
822 BLOOD COUNT ABNORMAL 3 0.0002
823 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
824 FLATULENCE 11 0.0002
825 DELUSION 3 0.0002
826 LUNG INFECTION 3 0.0002
827 HAEMATOMA 5 0.0002
828 COGNITIVE DISORDER 9 0.0002
829 DIPLOPIA 5 0.0002
830 HYPERGLYCAEMIA 7 0.0002
831 PULMONARY HYPERTENSION 4 0.0002
832 EYE IRRITATION 11 0.0002
833 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
834 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
835 HYPOTHYROIDISM 6 0.0002
836 BONE PAIN 11 0.0002
837 CHILLS 22 0.0002
838 HYPOACUSIS 8 0.0002
839 JAUNDICE 5 0.0002
840 INJECTION SITE ERYTHEMA 23 0.0002
841 BLOOD POTASSIUM INCREASED 3 0.0002
842 SEPTIC SHOCK 8 0.0002
843 BLOOD CREATININE INCREASED 12 0.0002
844 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
845 HEART RATE INCREASED 18 0.0002
846 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
847 ABNORMAL DREAMS 5 0.0002
848 DRUG ABUSE 15 0.0002
849 SYNCOPE 18 0.0002
850 TRANSAMINASES INCREASED 4 0.0002
851 RASH MACULO-PAPULAR 4 0.0002
852 INJECTION SITE PRURITUS 12 0.0002
853 PULMONARY OEDEMA 8 0.0002
854 EYE PRURITUS 6 0.0002
855 ANGER 6 0.0002
856 INJECTION SITE BRUISING 14 0.0002
857 HYPERSOMNIA 5 0.0002
858 PARANOIA 3 0.0002
859 SHOCK 4 0.0002
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
861 MUSCLE TWITCHING 4 0.0002
862 EMOTIONAL DISTRESS 21 0.0002
863 HOT FLUSH 13 0.0002
864 NERVOUSNESS 9 0.0002
865 RENAL DISORDER 8 0.0002
866 HYPERKALAEMIA 6 0.0002
867 DERMATITIS ATOPIC 9 0.0002
868 COLD SWEAT 3 0.0002
869 GOUT 3 0.0002
870 LEUKOCYTOSIS 3 0.0002
871 PELVIC PAIN 3 0.0002
872 CORONARY ARTERY DISEASE 5 0.0002
873 CRYING 6 0.0002
874 DEHYDRATION 22 0.0002
875 PLEURAL EFFUSION 10 0.0002
876 DYSURIA 6 0.0002
877 ENCEPHALOPATHY 4 0.0002
878 DYSGEUSIA 12 0.0002
879 FEMUR FRACTURE 5 0.0002
880 MIDDLE INSOMNIA 3 0.0002
881 PNEUMONIA ASPIRATION 4 0.0002
882 ABDOMINAL PAIN LOWER 4 0.0002
883 DRY SKIN 21 0.0002
884 INCREASED APPETITE 3 0.0002
885 CHEST DISCOMFORT 16 0.0002
886 HIP FRACTURE 5 0.0002
887 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
888 UNRESPONSIVE TO STIMULI 4 0.0002
889 RASH GENERALISED 4 0.0002
890 LACTIC ACIDOSIS 5 0.0002
891 SKIN EXFOLIATION 13 0.0002
892 DYSPHONIA 9 0.0002
893 ECZEMA 8 0.0002
894 DISORIENTATION 6 0.0002
895 HAEMATOCRIT DECREASED 3 0.0002
896 CATARACT 9 0.0002
897 FULL BLOOD COUNT DECREASED 3 0.0001
898 FEAR 4 0.0001
899 DRUG EFFECT DECREASED 8 0.0001
900 BLINDNESS 6 0.0001
901 MULTIPLE SCLEROSIS 7 0.0001
902 RESPIRATORY ARREST 4 0.0001
903 PROCEDURAL PAIN 4 0.0001
904 MENTAL STATUS CHANGES 4 0.0001
905 INJECTION SITE SWELLING 11 0.0001
906 DERMATITIS 3 0.0001
907 DEMENTIA 4 0.0001
908 WITHDRAWAL SYNDROME 6 0.0001
909 ANGINA PECTORIS 4 0.0001
910 PRURITUS GENERALISED 3 0.0001
911 PRODUCT PRESCRIBING ISSUE 3 0.0001
912 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
913 NEEDLE ISSUE 4 0.0001
914 ACUTE MYOCARDIAL INFARCTION 4 0.0001
915 INJECTION SITE MASS 5 0.0001
916 URINARY INCONTINENCE 4 0.0001
917 ORAL PAIN 3 0.0001
918 CHROMATURIA 3 0.0001
919 HALLUCINATION 10 0.0001
920 HEPATIC FAILURE 4 0.0001
921 PRODUCT AVAILABILITY ISSUE 3 0.0001
922 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
923 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
924 HAEMATOCHEZIA 7 0.0001
925 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
926 THERAPY INTERRUPTED 9 0.0001
927 ABSCESS 2 0.0001
928 PANCYTOPENIA 7 0.0001
929 ABORTION SPONTANEOUS 5 0.0001
930 PRESYNCOPE 3 0.0001
931 DYSKINESIA 5 0.0001
932 PRODUCT DOSE OMISSION 8 0.0001
933 INFLUENZA LIKE ILLNESS 10 0.0001
934 OSTEONECROSIS OF JAW 3 0.0001
935 ANAEMIA 23 0.0001
936 BLOOD PRESSURE DECREASED 8 0.0001
937 PALPITATIONS 14 0.0001
938 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
939 CARDIOVASCULAR DISORDER 3 0.0001
940 FLUSHING 12 0.0001
941 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
942 HAEMORRHAGE 12 0.0001
943 HYPOXIA 4 0.0001
944 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
945 ATRIAL FIBRILLATION 11 0.0001
946 PAIN OF SKIN 3 0.0001
947 THROAT TIGHTNESS 3 0.0001
948 DRUG EFFECT INCOMPLETE 4 0.0001
949 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
950 MOOD ALTERED 3 0.0001
951 RESPIRATORY FAILURE 8 0.0001
952 SKIN IRRITATION 5 0.0001
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
954 INJECTION SITE PAIN 33 0.0001
955 TOXICITY TO VARIOUS AGENTS 18 0.0001
956 INTESTINAL OBSTRUCTION 4 0.0001
957 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
958 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
959 COMA 5 0.0001
960 ACUTE RESPIRATORY FAILURE 2 0.0001
961 PLASMA CELL MYELOMA 4 0.0001
962 INCORRECT DOSE ADMINISTERED 23 0.0001
963 CEREBROVASCULAR ACCIDENT 17 0.0001
964 IRRITABILITY 6 0.0001
965 LACRIMATION INCREASED 3 0.0001
966 CARDIAC ARREST 8 0.0001
967 AGITATION 7 0.0001
968 OSTEONECROSIS 3 0.0001
969 BLOOD GLUCOSE INCREASED 17 0.0001
970 LIP SWELLING 3 0.0001
971 HAEMATURIA 3 0.0001
972 ARRHYTHMIA 4 0.0001
973 BLOOD GLUCOSE DECREASED 4 0.0001
974 HYPOGLYCAEMIA 4 0.0001
975 NEUTROPENIA 11 0.0001
976 AGGRESSION 4 0.0001
977 DYSARTHRIA 3 0.0001
978 BRADYCARDIA 4 0.0001
979 FEBRILE NEUTROPENIA 5 0.0001
980 BREAST CANCER 7 0.0001
981 PLATELET COUNT DECREASED 8 0.0001
982 SKIN BURNING SENSATION 5 0.0001
983 VAGINAL HAEMORRHAGE 3 0.0001
984 MYOCARDIAL INFARCTION 12 0.0001
985 ACNE 5 0.0001
986 DRUG DOSE OMISSION 9 0.0001
987 PRODUCT SUBSTITUTION ISSUE 3 0.0001
988 ABNORMAL BEHAVIOUR 2 0.0001
989 CARDIAC FAILURE CONGESTIVE 4 0.0000
990 DRUG DEPENDENCE 8 0.0000
991 PROSTATE CANCER 4 0.0000
992 DRUG DOSE OMISSION BY DEVICE 3 0.0000